Naoaki Watanabe

<i>In Vitro</i> Activity of E1210, a Novel Antifungal, against Clinically Important Yeasts and Molds

Mamiko Miyazaki, Takaaki Horii, Katsura Hata et al. · Antimicrobial Agents and Chemotherapy · 2011 · 198 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +14

Human bronchial epithelial cell‐derived extracellular vesicle therapy for pulmonary fibrosis via inhibition of TGF‐β‐WNT crosstalk

Tsukasa Kadota, Yu Fujita, Jun Araya et al. · Journal of Extracellular Vesicles · 2021 · 181 citations · Full text

Life Sciences, Cell Biology, Pathobiology +17

E1210, a New Broad-Spectrum Antifungal, Suppresses Candida albicans Hyphal Growth through Inhibition of Glycosylphosphatidylinositol Biosynthesis

Naoaki Watanabe, Mamiko Miyazaki, Takaaki Horii et al. · Antimicrobial Agents and Chemotherapy · 2011 · 169 citations · Full text

Life Sciences, Biology, Microbiology +17

Efficacy of Oral E1210, a New Broad-Spectrum Antifungal with a Novel Mechanism of Action, in Murine Models of Candidiasis, Aspergillosis, and Fusariosis

Katsura Hata, Takaaki Horii, Mamiko Miyazaki et al. · Antimicrobial Agents and Chemotherapy · 2011 · 145 citations · Full text

Life Sciences, Microbiology, Pharmacology +15

Medicinal genetics approach towards identifying the molecular target of a novel inhibitor of fungal cell wall assembly

Kappei Tsukahara, Katsura Hata, Kazutaka Nakamoto et al. · Molecular Microbiology · 2003 · 115 citations

Life Sciences, Microbiology, Molecular Biology +17